nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—Acute interstitial nephritis—Sorafenib—thyroid cancer	0.115	0.244	CcSEcCtD
Triamterene—SCNN1G—saliva-secreting gland—thyroid cancer	0.0659	0.125	CbGeAlD
Triamterene—SCNN1B—saliva-secreting gland—thyroid cancer	0.0557	0.105	CbGeAlD
Triamterene—SCNN1A—saliva-secreting gland—thyroid cancer	0.0514	0.0974	CbGeAlD
Triamterene—SCNN1B—trachea—thyroid cancer	0.0429	0.0813	CbGeAlD
Triamterene—SCNN1G—thyroid gland—thyroid cancer	0.0402	0.0761	CbGeAlD
Triamterene—SCNN1A—trachea—thyroid cancer	0.0397	0.0751	CbGeAlD
Triamterene—SCNN1D—head—thyroid cancer	0.0357	0.0676	CbGeAlD
Triamterene—SCNN1B—thyroid gland—thyroid cancer	0.034	0.0643	CbGeAlD
Triamterene—SCNN1A—thyroid gland—thyroid cancer	0.0314	0.0594	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0302	0.0639	CcSEcCtD
Triamterene—SCNN1B—head—thyroid cancer	0.0301	0.0571	CbGeAlD
Triamterene—Nephrolithiasis—Vandetanib—thyroid cancer	0.0287	0.0609	CcSEcCtD
Triamterene—SCNN1A—head—thyroid cancer	0.0278	0.0527	CbGeAlD
Triamterene—SCNN1D—lymph node—thyroid cancer	0.025	0.0473	CbGeAlD
Triamterene—SCNN1B—lymph node—thyroid cancer	0.0211	0.04	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.0203	0.0431	CcSEcCtD
Triamterene—SCNN1A—lymph node—thyroid cancer	0.0195	0.0369	CbGeAlD
Triamterene—Hypokalaemia—Vandetanib—thyroid cancer	0.0153	0.0323	CcSEcCtD
Triamterene—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0132	0.028	CcSEcCtD
Triamterene—Renal failure acute—Sorafenib—thyroid cancer	0.0122	0.0259	CcSEcCtD
Triamterene—Hypokalaemia—Sorafenib—thyroid cancer	0.0103	0.0218	CcSEcCtD
Triamterene—Jaundice—Sorafenib—thyroid cancer	0.00849	0.018	CcSEcCtD
Triamterene—Dry mouth—Vandetanib—thyroid cancer	0.00841	0.0178	CcSEcCtD
Triamterene—Thrombocytopenia—Vandetanib—thyroid cancer	0.00807	0.0171	CcSEcCtD
Triamterene—CYP1A2—thyroid gland—thyroid cancer	0.00754	0.0143	CbGeAlD
Triamterene—Fatigue—Vandetanib—thyroid cancer	0.0071	0.015	CcSEcCtD
Triamterene—Asthenia—Vandetanib—thyroid cancer	0.00591	0.0125	CcSEcCtD
Triamterene—Dry mouth—Sorafenib—thyroid cancer	0.00567	0.012	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—thyroid cancer	0.00566	0.012	CcSEcCtD
Triamterene—Diarrhoea—Vandetanib—thyroid cancer	0.00564	0.0119	CcSEcCtD
Triamterene—Anaphylactic shock—Sorafenib—thyroid cancer	0.00556	0.0118	CcSEcCtD
Triamterene—Dizziness—Vandetanib—thyroid cancer	0.00545	0.0115	CcSEcCtD
Triamterene—Thrombocytopenia—Sorafenib—thyroid cancer	0.00544	0.0115	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—thyroid cancer	0.00544	0.0115	CcSEcCtD
Triamterene—Vomiting—Vandetanib—thyroid cancer	0.00524	0.0111	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00523	0.0111	CcSEcCtD
Triamterene—Rash—Vandetanib—thyroid cancer	0.00519	0.011	CcSEcCtD
Triamterene—Dermatitis—Vandetanib—thyroid cancer	0.00519	0.011	CcSEcCtD
Triamterene—Headache—Vandetanib—thyroid cancer	0.00516	0.0109	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—thyroid cancer	0.00503	0.0107	CcSEcCtD
Triamterene—Nausea—Vandetanib—thyroid cancer	0.00489	0.0104	CcSEcCtD
Triamterene—Fatigue—Sorafenib—thyroid cancer	0.00479	0.0102	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—thyroid cancer	0.00476	0.0101	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—thyroid cancer	0.00453	0.00959	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—thyroid cancer	0.0044	0.00933	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—thyroid cancer	0.00419	0.00887	CcSEcCtD
Triamterene—Hypersensitivity—Sorafenib—thyroid cancer	0.00409	0.00867	CcSEcCtD
Triamterene—Asthenia—Sorafenib—thyroid cancer	0.00399	0.00845	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—thyroid cancer	0.0038	0.00806	CcSEcCtD
Triamterene—Diarrhoea—Sorafenib—thyroid cancer	0.0038	0.00806	CcSEcCtD
Triamterene—Dizziness—Sorafenib—thyroid cancer	0.00368	0.00779	CcSEcCtD
Triamterene—Vomiting—Sorafenib—thyroid cancer	0.00353	0.00749	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—thyroid cancer	0.00352	0.00745	CcSEcCtD
Triamterene—Rash—Sorafenib—thyroid cancer	0.0035	0.00742	CcSEcCtD
Triamterene—Dermatitis—Sorafenib—thyroid cancer	0.0035	0.00742	CcSEcCtD
Triamterene—Headache—Sorafenib—thyroid cancer	0.00348	0.00738	CcSEcCtD
Triamterene—Nausea—Sorafenib—thyroid cancer	0.0033	0.00699	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—thyroid cancer	0.0033	0.00698	CcSEcCtD
Triamterene—Jaundice—Epirubicin—thyroid cancer	0.00314	0.00665	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00305	0.00646	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—thyroid cancer	0.0029	0.00615	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—thyroid cancer	0.0021	0.00444	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—thyroid cancer	0.00205	0.00435	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—thyroid cancer	0.00201	0.00426	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—thyroid cancer	0.00194	0.00411	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0019	0.00403	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00186	0.00394	CcSEcCtD
Triamterene—Fatigue—Epirubicin—thyroid cancer	0.00177	0.00375	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—thyroid cancer	0.00164	0.00347	CcSEcCtD
Triamterene—Hypersensitivity—Epirubicin—thyroid cancer	0.00151	0.00321	CcSEcCtD
Triamterene—Asthenia—Epirubicin—thyroid cancer	0.00147	0.00312	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—thyroid cancer	0.00141	0.00298	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—thyroid cancer	0.0014	0.00297	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—thyroid cancer	0.00136	0.00289	CcSEcCtD
Triamterene—Dizziness—Epirubicin—thyroid cancer	0.00136	0.00288	CcSEcCtD
Triamterene—Vomiting—Epirubicin—thyroid cancer	0.00131	0.00277	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—thyroid cancer	0.0013	0.00275	CcSEcCtD
Triamterene—Rash—Epirubicin—thyroid cancer	0.0013	0.00274	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—thyroid cancer	0.00129	0.00274	CcSEcCtD
Triamterene—Headache—Epirubicin—thyroid cancer	0.00129	0.00273	CcSEcCtD
Triamterene—Dizziness—Doxorubicin—thyroid cancer	0.00126	0.00266	CcSEcCtD
Triamterene—Nausea—Epirubicin—thyroid cancer	0.00122	0.00258	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—thyroid cancer	0.00121	0.00256	CcSEcCtD
Triamterene—Rash—Doxorubicin—thyroid cancer	0.0012	0.00254	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—thyroid cancer	0.0012	0.00254	CcSEcCtD
Triamterene—Headache—Doxorubicin—thyroid cancer	0.00119	0.00252	CcSEcCtD
Triamterene—Nausea—Doxorubicin—thyroid cancer	0.00113	0.00239	CcSEcCtD
